The Centers for Medicare & Medicaid Services (CMS) is widely expected to show some love…
State Sen. Dennis Baxley, R-Ocala, In Tallahassee, is sponsoring so-called the Vulnerable Child Protection Act. His bill would make it a felony for doctors to provide hormonal therapies, gender reassignment surgeries and other medical treatment for minors who…
Researchers led by a team at Massachusetts Eye and Ear have identified a novel cellular entry factor for adeno-associated virus vector (AAV) types–the most commonly used viral vectors for in vivo gene therapy. AAVs are vectors-or vehicles–that are…
For years, the usual protocol in patients with blocked arteries has been for doctors to perform angioplasty, inserting a tiny mesh tube known as a stent to keep the artery open. The procedure is performed nearly a million…
Michael R. Jaff
There is now plentiful evidence that medical therapy benefits patients with peripheral artery disease, which is reflected in guidelines but not followed nearly enough, a speaker stated at the International Symposium on Endovascular Therapy.
“We…
Researchers at the University of Maryland School of Medicine (UMSOM) developed a new nanoparticle drug formulation that targets a specific receptor on cancer cells and appears to be more effective than a standard nanoparticle therapy currently…
Much attention has been given to the recent November 26, 2019 JAMA article that concluded U.S. life expectancy has declined for the past three years as a result of increased mortality among middle-aged adults from what has been…
William Schlaff, MD
Women with uterine fibroids who used elagolix (Orilissa) with add-back therapy saw a reduction in heavy menstrual bleeding.
Abnormal bleeding is 1 of the most common indications of uterine fibroids…
